Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. Where some medtech leaders might see GLP-1 drugs as a big threat to their territory, Farrell sees it as an opportunity to funnel more people toward CPAP treatment by boosting awareness of chronic diseases like sleep apnea, and driving more people who suffer from these diseases into treatment pathways they may not have been previously open to or aware of, such as CPAP machines
Understanding the evidence, safety profile, and appropriate use of these supplements is essential for informed decision-making and safe practice
Regular provider visits and lab checks help catch and manage any issues early
Bisgaard LS, Bosteen MH, Fink LN, Srensen CM, Rosendahl A, Mogensen CK, Rasmussen SE, Rolin B, Nielsen LB, Pedersen TX
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
